Clostridium difficile toxin A (TcdA) is a major exotoxin contributing to disruption of the colonic epithelium during C. difficile infection. TcdA contains a carbohydrate-binding CROPs (combined repetitive oligopeptides) domain that mediates its attachment to cell surfaces, but recent data suggest the existence of CROPs-independent receptors. Here we carried out genome-wide CRISPR-Cas9-mediated screens using a truncated TcdA lacking the CROPs and identified sulfated glycosaminoglycans (sGAGs) and low-density lipoprotein receptor (LDLR) as host 
Introduction
C. difficile is a spore-forming opportunistic pathogen and one of the three "urgent threats"
classified by the Centers for Disease Control and Prevention (CDC) of the United States. Disruption of gut flora by antibiotics allows C. difficile to colonize the colon, leading to diarrhea and life-threatening pseudomembranous colitis 1 . The occurrence of C. difficile infection (CDI) is exacerbated by the emergence of hyper-virulent and antibiotic-resistant strains [2] [3] [4] . It is now the most common cause of antibiotic-associated diarrhea and gastroenteritis-associated death in developed countries, accounting for a half million cases and ~29,000 deaths annually in the United States 5 .
Two homologous exotoxins, TcdA and TcdB, which target and disrupt the colonic epithelium, are the major virulent factors of C. difficile [6] [7] [8] [9] [10] . In addition, some hypervirulent strains also express the third toxin known as C. difficile transferase (CDT), which suppresses host eosinophilic responses 11 . TcdA (~308 kDa) and TcdB (~270 kDa) consist of four functional domains 10, 12 : the N-terminal glucosyltransferase domain (GTD), a cysteine protease domain (CPD) that mediates auto-cleavage and releases the GTD into the host cytosol, a central part containing both the transmembrane delivery domain and receptorbinding domain, and finally a C-terminal CROPs (combined repetitive oligopeptides) domain. The GTD glucosylates small GTPases of the Rho family, including Rho, Rac, and CDC42, and inhibits their function, resulting in cytopathic cell-rounding and ultimately cell death.
full-length TcdA: sucrase-isomaltase and glycoprotein 96 (Gp96) 22, 23 . However, sucraseisomaltase is not expressed in the colon epithelium and Gp96 resides mainly in the endoplasmic reticulum (ER).
Here we utilized a truncated TcdA lacking the majority of the CROPs domain and carried out genome-wide CRISPR-Cas9-mediated knockout (KO) screens, which identified sulfated glycosaminoglycans (sGAGs) and low-density lipoprotein receptor (LDLR) as CROPsindependent host factors mediating binding and entry of TcdA.
Results

CRISPR screens identify host factors for TcdA
To identify the CROPs-independent receptors involved in TcdA actions, we utilized a truncated TcdA (TcdA ) lacking the majority of the CROPs domain ( Supplementary  Fig. 1a ), which has been previously shown to retain high levels of toxicity on multiple cell lines 17 . We first validated the toxicity of TcdA 1-1874 on various human cell lines using the standard cytopathic cell-rounding assay, which measures the percentages of rounded cells after incubation with a series of concentrations of toxins for 24 h ( Supplementary Fig. 1b, c) . The toxin concentration that induces 50% of cells to become round is defined as CR 50 , which is utilized to compare the sensitivity of different cell lines to TcdA . HeLa cells, which is one of the most sensitive human cell lines to TcdA , was selected to carry out genome-wide CRISPR-Cas9 mediated KO screens.
HeLa cells stably expressing Cas9 were transduced with a lentiviral sgRNA library (GeCKO v2) targeting 19,052 human genes 24 . The cells were subjected to three rounds of selection with TcdA (40, 80 , and 160 pM, Fig. 1a ). The genes targeted by sgRNAs in surviving cells were identified via next-generation sequencing (NGS). We ranked the target genes based on the number of unique sgRNAs (y-axis) and the total NGS reads (x-axis) (Fig. 1b) . All top ranked genes were enriched over the three rounds, suggesting that mutations in these genes offered survival advantages in the presence of TcdA (Fig. 1c) .
The top-ranked gene encodes LDLR, a well-known receptor for low-density lipoproteins. Many other top ranked genes encode key players in heparan sulfate (HS) biosynthesis and sulfation pathways 25 , including the glycosyltransferases Exostosin-2 (EXT2) and Exostosin like-3 (EXTL3), sulfotransferases Heparan Sulfate 6-O-Sulfotransferase 1 (HS6ST1) and NDeacetylase And N-Sulfotransferase 1 (NDST1), and Solute Carrier Family 35 Member B2 (SLC35B2), which transports the activated form of sulfate into Golgi. Several other enzymes involved in glycosaminoglycan (GAG) synthesis were also identified ( Supplementary Fig.  2a ). HS is usually attached to core proteins as heparan sulfate proteoglycans (HSPGs). Both HSPGs and LDLR are widely expressed on the surface of various cells, and thereby promising receptor candidates for TcdA.
GTPases 26 . ATP6V0D1 is a component of vacuolar-type H + -ATPase for acidification of endosomes, which is an essential condition to trigger translocation of TcdA and TcdB 27, 28 . PI4KB is a key player in phospholipid metabolism/signaling and its role in toxin action remains to be established.
Other notable top hits include COG5, COG7, TMEM165, and RIC8A. COG5 and COG7 are members of the conserved oligomeric Golgi (COG) complex 29 . In fact, all eight COG members were identified in the final round of screening ( Supplementary Fig. 2c ). TMEM165 is a multi-pass transmembrane protein localized to the Golgi. Although the exact function of the COG complex and TMEM165 remains to be fully established, mutations in COG complex and TMEM165 both result in congenital disorders of glycosylation 29, 30 , and affect multiple glycosylation pathways including biosynthesis of HS [31] [32] [33] . RIC8A is a guanine nucleotide exchange factor and its role in TcdA action remains to be validated.
We also performed a genome-wide CRISPR-Cas9-mediated KO screen using full-length TcdA in parallel on HeLa cells ( Supplementary Fig. 2d ). However, this screen only yielded UGP2 as the top hit. Two other hits, SGMS1 and ZNF283, are barely over our threshold. SGMS1 regulates lipid raft formation and may affect the endocytosis process. ZNF283 is a cytosolic protein, and its role in TcdA action remains to be validated. Lack of potential receptor candidates in the top hits suggests that full-length TcdA may utilize multiple receptors and entry pathways.
sGAGs contribute to cellular entry of TcdA 1-1832
TcdA 1-1874 still contains a short fragment of the CROPs domain, we further generated a truncated TcdA (TcdA ) that deletes the entire CROPs in order to exclude any potential contribution from the residual CROPs domain (Supplementary Fig. 1a ). TcdA and TcdA showed similar potency on HeLa cells in the cytopathic cell-rounding assays ( Supplementary Fig. 1b ).
Using TcdA 1-1832 , we first validated the role of EXT2 and EXTL3, as they are specifically required for the elongation of the HS chain, but not other types of GAGs. We generated EXT2 and EXTL3 KO HeLa cell lines using the CRISPR-Cas9 system. Both cell lines showed a reduction of cell surface HS levels compared to wild type (WT) cells, measured by flow cytometry analysis using an HS antibody ( Supplementary Fig. 3a ). Both EXT2 and EXTL3 KO cells showed a modest 4 to 5-fold reduction in sensitivity to TcdA compared with wild type (WT) cells, while their sensitivities toward TcdB 1-1830 remained the same as WT cells (Fig. 2a) .
Several top-ranked genes identified in our screen, including SLC35B2, NDST, HS6ST, HS2ST, and HS3ST, are involved in sulfation of GAGs 25 ( Supplementary Fig. 2a) . To examine the role of sulfation, we generated three single clones of SLC35B2 KO HeLa cells using the CRISPR-Cas9 approach. Reduction of HS in these cells was confirmed by flow cytometry analysis (Supplementary Fig. 3b ). These cell lines all showed ~10-fold reduction in sensitivity toward TcdA 1-1832 compared with WT cells, while their sensitivities toward TcdB were not changed (Fig. 2b) . The reduced sensitivity of SLC35B2 KO cells to TcdA was further confirmed by immunoblot analysis detecting RAC1 glucosylation (Supplementary Fig. 4a ). Finally, SLC35B2 KO cells also showed ~3-fold reduction in sensitivity to full-length TcdA (Fig. 2c) .
Characterizing the specificity of TcdA-sGAGs interactions
We next carried out competition assays to further validate the role of sGAGs. We first utilized surfen (bis-2-methyl-4-amino-quinolyl-6-carbamide), which is a small molecule that binds to and neutralizes negative charges on all sGAGs 34 . Pre-incubation of cells with surfen protected HeLa cells from TcdA 1-1832 in a concentration dependent manner, while it offered no protection from TcdB (Fig. 2d, Supplementary Fig. 5a ). Similar results were observed with Huh7 cells as well (Supplementary Fig. 5b ).
To understand the selectivity of TcdA-GAG interactions, we next carried out competition assays using a panel of GAGs including HS, heparin, De-N-sulfated heparin, N-acetyl-de-Osulfated heparin, chondroitin sulfate (CS), and dextran sulfate (DS). Heparin is a highly sulfated variant of HS and it is widely utilized as an anticoagulant. In addition, we also tested synthetic sulfated molecules GM-1111 and sulfated cyclodextrin. GM-1111 contains the same carbohydrate moieties and sulfation groups as HS, but with distinct glycosidic bonds. It has been developed as a HS mimic with reduced anti-coagulation activities 35 . Sulfated cyclodextrin is a small molecule distinct from GAGs. Non-sulfated GAG hyaluronic acid (HA) and polysaccharide cellulose were also examined. The schematic drawings of these molecules are illustrated in Supplementary Fig. 6 .
Pre-incubation of TcdA 1-1832 with HS, heparin, CS, DS, GM-1111, and sulfated cyclodextrin all reduced the level of cell-rounding, while HA showed no effect (Fig. 2e) . These results suggest that TcdA may not recognize HS specifically, but rather interacts mainly with the sulfation group. Furthermore, the finding that De-N-sulfated heparin protected cells from TcdA , whereas N-Acetyl-de-O-sulfated heparin did not offer any protection (Fig. 2e) , suggests that TcdA preferentially recognizes O-sulfation.
To further characterize direct TcdA-sGAG interactions, we utilized bio-layer interferometry (BLI) assay by immobilizing biotinylated heparin onto the probe. Binding of TcdA to the immobilized heparin would result in a shift in the light interference pattern that can be monitored in real-time. Biotinylated hyaluronate and cellulose were analyzed in parallel as controls. Both full-length TcdA and TcdA showed robust binding to biotin-heparin, but not to biotin-hyaluronate and biotin-cellulose (Fig. 2f, Supplementary Fig. 7a ). TcdAheparin interactions appear to be influenced by ionic strength of the buffer: higher salt concentrations reduce heparin-TcdA interactions ( Supplementary Fig. 7b ). At 150 mM salt concentrations, the apparent dissociation constants (K D ) for TcdA-heparin and TcdA 1-1874 -heparin are at similar levels (85.5 nM for TcdA 1-1874 versus 23.2 nM for full-length TcdA, Supplementary Fig. 7c -e).
LDLR contributes to cellular entry of TcdA 1-1832
To validate the role of LDLR, we generated LDLR KO HeLa cells using the CRISPR-Cas9 system. Three single KO clones were established and the loss of LDLR expression were confirmed by immunoblot analysis (Fig. 3a) . All three KO lines showed reduced sensitivity by ~ 7-fold to TcdA , while their sensitivity to TcdB 1-1830 remained the same as WT cells (Fig. 3b) . The reduced sensitivity of LDLR KO cells to TcdA was also confirmed by immunoblot analysis detecting RAC1 glucosylation ( Supplementary Fig. 4b ). LDLR −/− cells also showed ~3-fold reduction in sensitivity to full-length TcdA, thus validating the role of LDLR for full-length TcdA (Fig. 3c) . The sensitivity to TcdA was restored when LDLR KO cells were transfected with mouse Ldlr (Fig. 3d) , which is not targeted by the sgRNA. Furthermore, Huh7 LDLR −/− cells, which were previously generated and validated 36 , also showed reduced sensitivity to TcdA 1-1832 compared to WT Huh7 cells ( Supplementary Fig. 8 ).
We further carried out a competition assay using the soluble extracellular domain of LDLR (residues 22-788, LDLR ). Co-incubation of LDLR with TcdA 1-1832 (200:1) reduced the percentage of rounded cells (Fig. 3e) . LDLR belongs to a large family of proteins including VLDLR, LRP1, LRP1b, LRP2 (Megalin), LRP5, LRP6, and LRP8 (ApoER2), which share similar domains with LDLR and often act as redundant receptors for many LDLR ligands. RAP (receptor associated protein) binds tightly to most LDLR family members and its binding inhibits binding of LDL and many other ligands [37] [38] [39] . Adding RAP to the medium further reduced the sensitivity of LDLR KO cells to TcdA (Fig. 3f ), suggesting that other LDLR family members also contribute to TcdA 1-1832 entry into cells.
To examine binding of TcdA to LDLR in vitro, we utilized purified Fc-tagged extracellular domain of LDLR (LDLR 22-788 -Fc) produced in HEK293 cells. This LDLR -Fc mediated strong binding of RAP, but we did not detect direct binding of TcdA to LDLR 22-788 -Fc in either BLI assays or an alternative dot blot assay ( Supplementary Fig. 9 ). These results suggest that either TcdA 1-1874 binding to LDLR is weak or their interactions may require additional cellular factors.
sGAGs are major cellular attachment factors for TcdA To further understand the role of LDLR and sGAGs, we generated LDLR −/− /SLC35B2 −/− double KO cell lines by knocking out LDLR from HeLa SLC35B2 −/− cells using the CRISPR-Cas9 approach. Two single cell clones were established and lack of LDLR expression was confirmed by immunoblot (Fig. 4a) . However, these two double-KO cell lines did not further increase the resistance to TcdA 1-1832 compared with LDLR and SLC35B2 single KO cells (Fig. 4b, Supplementary Fig. 4c ). Moreover, overexpression of exogenous mouse Ldlr by transient transfection did not increase the sensitivity of SLC35B2 −/− cells to TcdA (Fig. 4c) . These data suggest that LDLR and sGAGs are not redundant receptors, and they could act cooperatively. We then examined binding of The colonic epithelium is the pathologically relevant target of TcdA. sGAGs are abundant both in the intestinal mucosa and on the basolateral side of the epithelium [40] [41] [42] . To examine the contribution of sGAGs to TcdA binding to the colonic epithelium, we utilized a colon loop ligation assay previously established 20 . Briefly, fluorescence-labelled TcdA 1-1874 was injected into a ligated colon segment and incubated for 30 min. Colon tissues were then dissected and fixed. TcdA showed strong binding to the apical side of the colonic epithelium and binding appears to extend into the lumen (Fig. 4e) . Co-injecting surfen reduced binding of TcdA (Fig. 4e) . Similarly, heparin, GM-1111, and sulfated cyclodextrin all reduce binding of TcdA , whereas HA showed no effect (Fig. 4f) . These results suggest that sGAGs are major attachment factors in the colon epithelium for TcdA .
Blocking sGAG-TcdA interactions reduces TcdA toxicity in the colon
We next examined the contribution of sGAGs-mediated binding in the context of full-length TcdA in vivo. Injecting fluorescence-labelled full-length TcdA into the ligated colon loop for 30 min resulted in robust binding to the apical side of the colonic epithelium (Fig. 5a ). Co-injecting recombinantly produced CROPs fragment reduced binding of TcdA, consistent with the finding that CROPs region mediates TcdA binding to cells 43 . Co-injecting surfen with TcdA reduced binding of TcdA, confirming that sGAGs contribute to binding of fulllength TcdA to the colonic epithelium (Fig. 5a) . Similarly, co-injection with GM-1111 or sulfated cyclodextrin reduced TcdA binding to the colonic epithelium as well (Fig. 5b) . Interestingly, combining CROPs and surfen together largely abolished binding of TcdA to the colonic epithelium (Fig. 5a) . Thus, both CROPs-mediated and sGAGs-mediated binding contributes to TcdA binding to the colonic epithelium.
To further examine the relevance of sGAG-TcdA interactions for TcdA-induced pathogenesis in vivo, we utilized a mouse cecum injection model previously established to assess pathogenesis of TcdA and TcdB 44 . Briefly, TcdA or TcdA pre-mixed with inhibitors was injected into the cecum. Mice were allowed to recover for 6 h before euthanization. The cecum plus the ascending colon was harvested and weighted to measure the degree of fluid accumulation. The cecum tissue was also fixed and subjected to hematoxylin and eosin (H&E) staining and histological score analysis based on four criteria (disruption of the epithelium, hemorrhagic congestion, mucosal edema, and inflammatory cell infiltration) on a scale of 0-3 (normal, mild, moderate, or severe). Injection of TcdA induced fluid accumulation in the colon tissues, severe mucosal edema, as well as mild to moderate disruption of the epithelium, hemorrhagic congestion, and inflammatory cell infiltration (Fig. 5c, d) .
Finding a suitable inhibitor however was challenging as HS and many sGAG mimics induced hemorrhages in the intestine and colon after incubation for 6 h. This is likely due to their anticoagulation activity. Surfen alone at the concentration required to reduce TcdA binding also induced damage to colonic tissues after incubation for 6 h. After surveying many different sGAG mimics, we found that GM-1111, which is specifically developed to reduce the anticoagulation activity, can be utilized at the dose that reduces TcdA binding without inducing visible tissue damage by itself. Co-injecting GM-1111 with TcdA significantly reduced fluid accumulation in the colon (cecum weight, Fig. 5c ) and overall tissue damage as evidenced by histological scoring (Fig. 5d) .
Discussion
The presence of numerous negatively charged sulfate groups in sGAGs provides an ideal multi-valent landing pad for proteins and macromolecules through electrostatic interactions. They are known to interact with a large array of endogenous ligands, such as fibroblast growth factors (FGFs), vascular endothelial growth factor (VEGF), transforming growth factor β (TGFβ), chemokines, and cytokines 45 . Not surprisingly, these proteoglycans are also exploited by a long list of viral, bacterial, and parasitic pathogens as attachment factors 46 . As TcdA is capable of binding to isolated sGAGs, it should be able to bind to both proteoglycans containing sGAGs as well as free sGAGs on the cell surface and in the extracellular matrix. The exact binding sites for sGAGs in TcdA remain to be determined and it is possible that multiple positively charged surface regions of TcdA are involved.
LDLR belongs to a family of structurally related receptors and many of them act as redundant receptors for various ligands and viruses 47 . Interestingly, a LDLR family member LRP1 was previously established as the receptor for TpeL toxin 39 , which belongs to the same toxin family as TcdA but naturally lacks the CROPs domain. It is likely that LDLR family members other than LDLR can also contribute to TcdA 1-1832 entry, as RAP further reduces the sensitivity of LDLR KO cells.
LDLR family of receptors are known to rapidly and constitutively recycle between cell membranes and endosomes. This provides an ideal portal to mediate endocytosis into cells. Indeed, LDLR has been exploited by many viruses as their receptors, such as vesicular stomatitis virus (VSV), hepatitis C virus, and the minor group common cold virus 36, 38, 48 . Although it remains unknown whether TcdA is capable of recognizing LDLR family members directly on cell surfaces, the major contribution of LDLR members is likely through facilitating endocytosis of TcdA bound to sGAGs. Similar synergistic actions between proteoglycan and LDLR family members are common for endogenous ligands. For instance, it was shown that HSPG contributes to the capture of PCSK9 onto cell surfaces and subsequently presents PCSK9 to LDLR 49 . Furthermore, many viruses that utilize HSPG as the initial attachment factor recruit additional protein receptors to mediate their endocytosis 50 . For instance, respiratory syncytial virus (RSV) utilizes HSPG as an attachment factor and ICAM1 and VLDLR as additional protein receptors 50 . Such a "twostep" model allows the pathogens and toxins to both maximize their chance of landing onto the cell surface, as well as taking advantage of rapid endocytosis and recycling of LDLR family members.
A combination of surfen and the CROPs domain protein largely abolished binding of fulllength TcdA to the colonic epithelium, demonstrating that TcdA attaches to the colonic epithelium via at least two independent binding interfaces: interactions with sGAGs in a CROPs-independent manner and interactions with carbohydrate moieties by the CROPs. These results are consistent with the previous finding that TcdA and TcdA 1875-2710 do not compete with each other, while both can reduce binding of full-length TcdA to cells 17 . These results further support a previously proposed "two-receptor" model for TcdA 10, 16, 39 . Finally, GM-1111 alone reduced the toxicity of TcdA in the cecum injection model in vivo, demonstrating the therapeutic potential of protecting colonic tissues from TcdA by targeting TcdA-sGAGs interactions.
Methods
Materials.
HeLa (H1, #CRL-1958), HT-29 (#HTB-38), CHO-C6, and 293T (#CRL-3216) cells were originally obtained from ATCC. They tested negative for mycoplasma contamination, but have not been authenticated. Huh7 and Huh7 LDLR −/− cells were kindly provided by Y.
Matsuura 36 . The following mouse monoclonal antibodies were purchased from the indicated vendors: RAC1 (23A8, Abcam), non-glucosylated RAC1 (Clone 102, BD Biosciences), β-actin (AC-15, Sigma), and HS (F58-10E4, mouse IgM, Amsbio). Rabbit monoclonal IgG against LDLR (EP1553Y) was purchased from Abcam. Chicken polyclonal IgY (#753A) against TcdA was purchased from List Biological Labs. Statistical analysis was performed using OriginPro 8 (V8.0724, OriginLab Corp.) software.
Protein purification.
Recombinant TcdA (from C. difficile strain VPI 10463), TcdA 1-1874 , TcdA , and CROPs (TcdA 1875-2710 ) were cloned into modified pWH1520 vector, and TcdB 1-1830 into pHIS1522 vector and expressed in Bacillus megaterium and purified as His6-tagged proteins. The expression plasmid pQTEV-LRPAP1 (#31327) encoding RAP was obtained from Addgene and RAP was purified as a His6-tagged protein. Genes encoding the ectodomain of human LDLR (residues 22-788) and IgG1-Fc were fused and cloned into pHLsec vector (kindly provided by A. Jonathan). For the expression of Fc-tagged LDLR , HEK293T cells were transfected with Lipofectamine™ 3000 (Invitrogen). Transfected cells were grown for 5 h, followed by replacing the culture medium with serum-free medium for 4 days. LDLR -Fc in the culture medium was collected and purified.
Genome-wide CRISPR-Cas9 screening with TcdA 1-1874 .
The HeLa CRISPR genome-wide knockout library was generated as previously described 20 . In short, the GeCKO v2 library is composed of two sub-libraries. Each sub-library contains three unique sgRNA per gene and was independently prepared and screened. HeLa-Cas9 Cells were transduced with sgRNA lentiviral library at a MOI (multiplicity of infection) of 0.2. For each CRISPR sub-library, 7.9×10 7 cells were plated onto three 15-cm cell culture dishes to ensure sufficient sgRNA coverage, with each sgRNA being represented around 1200 times. These cells were exposed to TcdA 1-1874 for 48 h. Cells were then washed three times to remove loosely attached cells. The remaining cells were cultured with toxin-free medium to ~70% confluence and subjected to the next round of screening with higher concentrations of toxins. Three rounds of screenings were performed with TcdA (40, 80 , and 160 pM). Remaining cells from each round were harvested and their genomic DNA extracted using the Blood and Cell Culture DNA mini kit (Qiagen). DNA fragments containing the sgRNA sequences were amplified by PCR using primers lentiGP-1_F (AATGGACTATCATATGCTTACCGTAACTTGAAAGTATTTCG) and lentiGP-3_R (ATGAATACTGCCATTTGTCTCAAGATCTAGTTACGC). Next-generation sequencing (Illumina MiSeq) was performed by a commercial vendor (Genewiz).
Generating HeLa KO cell lines. 
FACS analysis.
Briefly, cells were collected with 1 mM EDTA in PBS and subsequently re-suspended in PBS with 1% BSA. Cells were incubated with either the 10E4 monoclonal antibody against HS (1:400), or mouse IgM (1:200; ab18401, Abcam, Cambridge, MA) for 1 h on ice. Cells were washed twice with PBS and incubated with goat anti-mouse IgG/IgM Alexa488 (1:1000; A10680, Molecular Probes, Eugene, OR) for 1 h on ice, washed twice, and followed by single-cell sorting using a FACS MoFlo Astrios EQ (Cell sorter-Beckman coulter, Indianapolis, IN). Data was analyzed using FlowJo software (FlowJo Inc, Ashland, OR).
Cytopathic cell rounding assay.
The cytopathic effect of TcdA and TcdB was analyzed using the standard cell-rounding assay. Briefly, cells were exposed to TcdA, TcdA 1-1874 , TcdA 1-1832 , or TcdB 1-1830 for 24 h, and the phase-contrast images of cells were recorded (Olympus IX51, 10-20X objectives). A zone of 300×300 μm was selected randomly, which usually contains 50-150 cells. The numbers of normal shaped and round-shaped cells were counted manually. The percentage of round-shaped cells was analyzed using the Origin software.
Competition assays with GAGs or ecto-domain of LDLR.
TcdA 1-1832 (2 nM) was pre-mixed with or without 1 mg/ml HS (Sigma, H7640), chondroitin sulfate (CS), dextran sulfate (DS, Sigma, D4911), hyaluronic acid (HA, Sigma, 53747), heparin (Fisher Bioreagents, BP252450), De-N-sulfated heparin (Carbosynth, YD58544), N-acetyl-de-O-sulfated heparin (Carbosynth, YD58545), sulfated cyclodextrin (Sigma-Aldrich, 494542-5G), GM-1111 (Glycomira Inc., Salt Lake City, UT), or 400 nM LDLR in fresh DMEM medium and incubated at 37 °C for 20 min. The mixture was then added to the cells. Cells were further incubated at 37 °C and the percentage of rounded cells over time were recorded and analyzed.
Competition assays with RAP or surfen.
The cells were pre-incubated with RAP or surfen in the medium at indicated concentrations at 37 °C for 20 min. 2 nM TcdA 1-1832 was then added to the medium. Cells were further incubated at 37 °C and the percentage of rounded cells over time were recorded and analyzed.
Dot blot assay.
The indicated amounts of RAP, TcdA , and TcdB 1-1830 were spotted onto a nitrocellulose membrane and allowed to dry in the air completely. The membrane was then blocked with 5% skimmed milk for 1 h at room temperature followed by overnight incubation with LDLR 
Biolayer interferometry (BLI) assay.
The binding affinities between TcdA 1-1874 and heparin were measured by BLI assay using the Blitz system (ForteBio). Briefly, biotinylated heparin (20 μg/ml, B9806, Sigma-Aldrich), biotin-cellulose (Creative PEGWorks, CE501), or biotin-hyaluronate-biotin (Sigma, B1557) was immobilized onto capture biosensors (Dip and Read Streptavidin, ForteBio) and balanced with indicated buffers. The biosensors were then exposed to TcdA 1-1874 , followed by washing. Binding affinities (K D ) were calculated using the Blitz system software (ForteBio). The experiments were repeated in triplicates.
Colon loop ligation assay.
All animal studies were conducted in accordance with ethical regulations under protocols approved by the Institute Animal Care and Use Committee (IACUC) at Boston Children's Hospital (#3028). Statistical consideration was not used to determine the sample size of mice. Animals were distributed to each experimental group randomly. Experiments and data analysis were carried out without blinding. Colons from adult CD-1 mice (6-8 weeks, both male and female, from Envigo, NJ) were dissected out and incubated in PBS on ice. A ~2 cm loop in ascending colon was sealed with silk ligatures. 100 μl of Alexa555-labeled TcdA or TcdA (5 nM, each) in PBS was injected through an intravenous catheter into the sealed colon segment with and without the TcdA 1875-2710 (150 nM) and/or surfen (5 μM), GM-1111 (1 mg/mL), sulfated cyclodextrin (1 mg/mL). The colon segments were incubated on ice for 30 min, then cut open, washed with PBS, fixed with paraformaldehyde, and subjected to cryosectioning into sections of 10 μm thick. Confocal images were captured with the Ultraview Vox Spinning Disk Confocal System. Toxin binding was quantified using ImageJ software. The binding signal intensity was averaged based on the length of the epithelium. Three images were analyzed; the p-value was calculated by Student's t-test.
Cecum injection assay.
Mice (CD1, 6-8 weeks, male and female, Envigo, NJ) were anesthetized with 3% Isoflurane after overnight fasting. A midline laparotomy was performed. TcdA (4 μg in 100 μl saline), TcdA premixed with GM-1111(4 μg TcdA + 0.5 mg/ml GM-1111), or saline was injected into the cecum through the ileocecal junction. The gut was then put back to the abdomen. The incision was closed with stitches and mice were allowed to recover. After 6 h, mice were euthanized and the cecum plus the ascending colon (~1.5 cm) was excised and weighed. The cecum tissue was fixed with 10% Phosphate Buffer Formalin and embedded in paraffin. Tissue sections were subjected to H&E staining for histological score analysis based on four criteria (disruption of the epithelium, hemorrhagic congestion, mucosal edema, and inflammatory cell infiltration) on a scale of 0-3 (normal, mild, moderate, or severe).
Data Availability
The data that support the findings of this study are available from the corresponding authors upon request.
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